Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FYQ18
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,685
Award facts
- Contract value 100% obligated
- $38,685.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,685 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of October 8, 2025, represents a discrete purchase under the agency's broader pharmaceutical supply framework. The contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis leveraging its established market position.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026 under the SPE2DB program. As a critical supplier in the federal pharmaceutical supply chain, the company provides comprehensive pharmaceutical distribution to Department of Defense healthcare facilities nationwide, including branded and generic prescription drugs, biologics, and medical consumables. The XOLAIR supply fulfills ongoing medical needs for military health facilities, consistent with DMS Pharmaceutical Group's established role in supporting federal healthcare operations across diverse therapeutic categories.
Quick answers
Who was awarded contract SPE2DB25FYQ18?
SPE2DB25FYQ18 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FYQ18 worth?
The government has obligated $38,685 on SPE2DB25FYQ18.
Is contract SPE2DB25FYQ18 an order under another contract?
Yes. SPE2DB25FYQ18 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYQ18 competed?
The extent of competition for SPE2DB25FYQ18 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award